Cargando…
A method of decision analysis quantifying the effects of age and comorbidities on the probability of deriving significant benefit from medical treatments
BACKGROUND: The external validity, or generalizability, of trials and guidelines has been considered poor in the context of multiple morbidity. How multiple morbidity might affect the magnitude of benefit of a given treatment, and thereby external validity, has had little study. OBJECTIVE: To provid...
Autores principales: | Fitzgerald, Stephen P., Bean, Nigel G., Ruberu, Ravi P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Swiss Medical Press GmbH
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556438/ https://www.ncbi.nlm.nih.gov/pubmed/29090189 http://dx.doi.org/10.15256/joc.2017.7.93 |
Ejemplares similares
-
Quantifying the probability of pharmacological success to inform compound progression decisions
por: Zhou, Xuan, et al.
Publicado: (2020) -
Clinical significance of microscopic polyangiitis with interstitial lung disease and bronchiectasis: probability of preexisting comorbidities
por: Zhang, Yun, et al.
Publicado: (2023) -
Quantifying the benefits of using decision models with response time and accuracy data
por: Stafford, Tom, et al.
Publicado: (2020) -
A Simplified Score to Quantify Comorbidity in COPD
por: Putcha, Nirupama, et al.
Publicado: (2014) -
A probability formula derived from serum indicators, age, and comorbidities as an early predictor of dementia in elderly Chinese people
por: Gong, Qing, et al.
Publicado: (2021)